SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-23-000024
Filing Date
2023-06-29
Accepted
2023-06-29 16:24:38
Documents
13
Period of Report
2023-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biib-20230626.htm   iXBRL 8-K 57092
  Complete submission text file 0000875045-23-000024.txt   241113

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20230626.xsd EX-101.SCH 2283
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20230626_lab.xml EX-101.LAB 24139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20230626_pre.xml EX-101.PRE 24562
7 EXTRACTED XBRL INSTANCE DOCUMENT biib-20230626_htm.xml XML 4083
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 231057734
SIC: 2836 Biological Products, (No Diagnostic Substances)